CAPTRUST Financial Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-30
| Closed | – | – | 4459 |
|
2022
Q2 | $0 | Buy |
+30
| New | – | ﹤0.01% | 5240 |
|
2022
Q1 | – | Sell |
-30
| Closed | – | – | 5242 |
|
2021
Q4 | $0 | Hold |
30
| – | – | ﹤0.01% | 5007 |
|
2021
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 4835 |
|
2021
Q2 | $0 | Hold |
30
| – | – | ﹤0.01% | 4726 |
|
2021
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 4528 |
|
2020
Q4 | $0 | Buy |
30
+4
| +15% | – | ﹤0.01% | 3563 |
|
2020
Q3 | $0 | Sell |
26
-30
| -54% | – | ﹤0.01% | 3307 |
|
2020
Q2 | $0 | Buy |
+56
| New | – | ﹤0.01% | 2926 |
|
2019
Q4 | – | Sell |
-27
| Closed | – | – | 1928 |
|
2019
Q3 | $0 | Sell |
27
-15
| -36% | – | ﹤0.01% | 2055 |
|
2019
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 1891 |
|
2019
Q1 | $1K | Sell |
42
-26
| -38% | -$619 | ﹤0.01% | 1777 |
|
2018
Q4 | $2K | Hold |
68
| – | – | ﹤0.01% | 1509 |
|
2018
Q3 | $4K | Hold |
68
| – | – | ﹤0.01% | 1415 |
|
2018
Q2 | $5K | Buy |
+68
| New | +$5K | ﹤0.01% | 1333 |
|